TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Santen Pharmaceutical Co ( (JP:4536) ) has issued an announcement.
Santen Pharmaceutical Co., Ltd. has announced the disposal of treasury shares as part of its Performance Share Unit plan, which is a performance-linked stock remuneration initiative for its directors and corporate officers. This move is intended to provide medium- to long-term incentives and align the interests of its executives with those of shareholders. The disposal involves 57,909 shares at a price of 1,639.5 yen per share, totaling 94,941,804 yen. The plan was approved at the company’s Annual General Meeting, and the performance metrics for the assessment period from FY2022 to FY2024 were evaluated, resulting in a payout ratio based on relative total shareholder return and ESG-related metrics.
The most recent analyst rating on (JP:4536) stock is a Buy with a Yen2600.00 price target. To see the full list of analyst forecasts on Santen Pharmaceutical Co stock, see the JP:4536 Stock Forecast page.
More about Santen Pharmaceutical Co
Santen Pharmaceutical Co., Ltd., headquartered in Osaka, is a company that operates in the pharmaceutical industry. It focuses on developing and providing eye care products and solutions, aiming to enhance the quality of life for people worldwide.
Average Trading Volume: 1,409,416
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen556.4B
For detailed information about 4536 stock, go to TipRanks’ Stock Analysis page.